SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-119351
Filing Date
2021-04-16
Accepted
2021-04-16 16:07:02
Documents
12
Period of Report
2021-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d135735d8ka.htm   iXBRL 8-K/A 22317
  Complete submission text file 0001193125-21-119351.txt   144025

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sldb-20210302.xsd EX-101.SCH 2725
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20210302_lab.xml EX-101.LAB 18093
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20210302_pre.xml EX-101.PRE 11378
5 EXTRACTED XBRL INSTANCE DOCUMENT d135735d8ka_htm.xml XML 3472
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

IRS No.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38360 | Film No.: 21831534
SIC: 2836 Biological Products, (No Diagnostic Substances)